Accordingly, the enrichment of the glioma’s overlapping activated genes in those controlled by TCF3 is not highly statistically significant (Enrichr p-value < 0.01; adjusted p-value > 0.05; Table S2). This evidence concerns the gene TCF3 and central nervous system cancer.